VIE/COPN (VIE/COPN)

Vienna Stock Exchange: VIE/COPN · EUR

€61.5

-0.20 (-0.3%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	102.7M
Net income (ttm)	-6.4M
EPS (ttm)	-€0.39
P/E (forward)	937.0x
Dividend	€2.10 (3.42%)
Volume	4

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 102.7M
Net income (ttm): -6.4M
EPS (ttm): -€0.39
P/E (forward): 937.0x
Market cap: 1.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/E937

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1.2

P25 n/aP50 n/aP75 n/a

ROIC-2.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/COPN indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Netherlands
Country code	AT
Earnings date	2027-04-19
Employees	365
Employees change	3
Employees growth	0.84%
Enterprise value	EUR 871.2M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1997
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	NL0011832936
Last earnings date	2026-07-23
Last refreshed	2026-10-30
Market cap	EUR 1.1B
Next earnings date	2027-04-19
Price	EUR 61.50
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	vie/COPN
Website	https://www.cosmohealthconfidence.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	2,925.92x
Average P/E ratio (5Y)	1,495.72x
Earnings yield	-0.63%
EV/Sales	8.51x
FCF / EV yield	-2.82%
FCF yield	-2.33%
Forward P/E	936.97x
P/B ratio	1.85x
P/S ratio	10.31x
Price / tangible book value	4.83x
Price/EBITDA ratio	879.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-10.84%
EBITDA margin	1.17%
Gross margin	45.51%
Operating margin	-10.84%
Pretax margin	-3.93%
Profit margin	-6.19%
Profit per employee	EUR -17,403
Revenue per employee	EUR 281,340
ROA	-1.07%
ROA (5Y)	3.63%
ROCE	-1.66%
ROE	-1.19%
ROE (5Y)	6.9%
ROIC	-2.92%
ROIC (5Y)	8.11%
SBC / revenue	3.07%
Tax / revenue	2.1%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-65.25%
Gross profit growth (Q)	-14.6%
Gross profit growth 3Y	-9.04%
Gross profit growth 5Y	6%
Net income growth years	0
Revenue growth	-43.66%
Revenue growth (Q)	-2.87%
Revenue growth (QoQ)	-4.23%
Revenue growth 10Y	3.57%
Revenue growth 3Y	-0.5%
Revenue growth 5Y	10.1%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.8M
Depreciation and amortization	EUR 12.3M
EBIT	EUR -11.1M
EBITDA	EUR 1.2M
EPS	EUR -0.39
Financing cash flow	EUR 95.2M
Free cash flow	EUR -24.7M
Free cash flow minus SBC	EUR -27.9M
Gross profit	EUR 46.7M
Income taxes	EUR 2.2M
Investing cash flow	EUR -94.8M
Net borrowing	EUR -1.1M
Net cash flow	EUR -20M
Net income	EUR -6.4M
Operating cash flow minus SBC	EUR -24.1M
Operating income	EUR -11.1M
Revenue	EUR 102.7M
Stock-based compensation	EUR 3.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.14
Book value per share	EUR 32.88
Debt / EBITDA	2.2
Debt / equity	0.01
Goodwill	EUR 24M
Interest coverage	-65.87
Long-term assets	EUR 431M
Long-term liabilities	EUR 96.9M
Net cash (debt)	EUR 190.4M
Net cash / market cap	17.99%
Net cash growth	53.61%
Net debt / EBITDA	-158.11
Net debt / equity	-0.33
Piotroski F-Score	2
Property, plant and equipment	EUR 30.7M
Shareholders' equity	EUR 572M
Tangible book value	EUR 219.2M
Tangible book value per share	EUR 12.75
Total assets	EUR 693.5M
Total cash	EUR 194.7M
Total debt	EUR 4.3M
Total liabilities	EUR 121.5M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.16
Current assets	EUR 262.5M
Current liabilities	EUR 24.6M
Current ratio	10.66
Inventory turnover	4.33
Net working capital	EUR 43.9M
Quick ratio	9.84
Working capital	EUR 237.9M
Working capital turnover	0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.95%
Dividend growth	2.44%
Dividend growth years	1
Dividend payment date	2026-05-11
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	EUR 2.10
Dividend yield	3.42%
Ex-dividend date	2026-04-24
Last dividend	EUR 2.10
Shareholder yield	2.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 72.35
1D price change	-0.32%
1M price change	3.54%
1M total return	3.54%
1W price change	7.33%
1W total return	7.33%
1Y price change	-15.17%
1Y return CAGR	-13.41%
1Y total return	-13.4%
20-day SMA	EUR 56.86
200-day SMA	EUR 83.29
3M price change	-8.07%
3M total return	-8.07%
50-day SMA	EUR 58.30
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 141.00
52-week high date	2026-02-03
52-week low	EUR 53.00
52-week low date	2026-10-15
6M price change	-32.86%
6M total return	-32.86%
All-time high	EUR 141.00
All-time high date	2026-02-03
All-time low	EUR 44.80
All-time low date	2025-04-29
Average true range (ATR)	EUR 1.53
Average volume	3.9
Change from 52-week high	-56.38%
Change from 52-week low	16.04%
Change from all-time high	-56.38%
Change from all-time low	37.28%
Change from open	-1.28%
Day's gap	0.97%
Dollar volume	EUR 246
High price	EUR 62.30
Low price	EUR 61.10
Monthly RSI	39.56
Open price	EUR 62.30
Position in 52-week range	33.33%
Previous close	EUR 61.70
Price vs 150-day SMA	-14.99%
Price vs 20-day SMA	8.17%
Price vs 200-day SMA	-26.17%
Price vs 50-day SMA	5.5%
Relative volume	0.99
RSI	63.66
Sharpe ratio	-0.16
Sortino ratio	-0.13
Volume	4
Weekly RSI	41.12
YTD price change	-46.52%
YTD total return	-45.4%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9.6M
Shares change (QoQ)	6.73%
Shares change (YoY)	0.95%
Shares held by institutions	15.91%

Deeper analysis on VIE/COPN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/COPN report

Is a complete VIE/COPN research report available?

No complete published report is available for vie/COPN (VIE/COPN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/COPN (VIE/COPN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/COPN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/COPN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/COPN

Frequently asked questions